跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 12,073 条关于
“M4 receptor”
全部
12,073
临床试验
5,792
药物
1,318
机构
30
资讯
4,933
8个月前
Neurosterix Initiates Phase 1 Trial of NTX-253, Novel M4 Receptor Modulator for Schizophrenia Treatment
去年
Neumora Therapeutics Initiates Phase 1 Trial of Novel M4 Receptor Modulator NMRA-861 for Schizophrenia
10个月前
Neumora Therapeutics Initiates Phase 1 Trial for Second M4 Muscarinic Receptor Modulator NMRA-898
去年
AbbVie's Emraclidine Fails to Meet Endpoints in Phase 2 Schizophrenia Trials
去年
FDA Approves Cobenfy, a Novel Schizophrenia Treatment Targeting Cholinergic Receptors
24天前
FDA Clears IND for Neurocrine and Nxera's Oral M1 Agonist NBI-1117567 in Alzheimer's Cognition
2年前
Cerevel Therapeutics Advances Emraclidine Development for Alzheimer's-Related Dementia and Psychosis
去年
AbbVie's Emraclidine Fails in Phase II Schizophrenia Trials, Shares Plummet
去年
AbbVie's Emraclidine Fails in Phase 2 Schizophrenia Trials, Benefiting BMS
9个月前
Schizophrenia Drug Pipeline Surges with 60+ Therapies from 55+ Companies as Novel Mechanisms Enter Late-Stage Development
第 1 页,共 494 页
上一页
下一页